Radio and PodcastRadio and PodcastLive Radio & Podcasts
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine artwork
Science & Medicine

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine

JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association

Jan 6, 202518:09Science & Medicine

Interview with Wei-Hsuan Lo-Ciganic, PhD, author of Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. Hosted by Cynthia E. Armand, MD. Related Content: Card...

About This Episode

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine is an episode from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and funct...

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jan 6, 2025, 18:09 long, audio available.

Questions About This Episode

What is Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine about?

Interview with Wei-Hsuan Lo-Ciganic, PhD, author of Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. Hosted by Cynthia E. Armand, MD. Related Content: Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine

Where can I listen to Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine?

You can listen to Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine from?

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine is an episode from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association.

How long is this episode?

This episode is 18:09 long.

When was this episode published?

This episode was published on Jan 6, 2025.

Can I save Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system?

Yes. This page shows related episodes from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine?

You can listen to Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine is from JAMA Neurology Author Interviews: Covering research, science, & clinical practice in the structure and function of the nervous system by American Medical Association.

What are the episode details?

Published Jan 6, 2025 and 18:09 long